Since 15 years, our research group works on a new therapeutic approach of chronic diseases [1,2], we present here new drug candidates able to fight against GRAM -bacteria and some multi-resistant ones. These drugs based on the synthesis of iatrogenic polypeptides on which are linked endogenous small sized molecules. The different bacterial strains used in this study were:
Since 15 years, our research group works on a new therapeutic approach of chronic diseases [1, 2] , we present here new drug candidates able to fight against GRAM -bacteria and some multi-resistant ones. These drugs based on the synthesis of iatrogenic polypeptides on which are linked endogenous small sized molecules. The different bacterial strains used in this study were: GRAM -strains: On the Petri dish test, the densitometric criteria of bacteria were always a value of 0.5 in the McFarland scale. The evaluation of the inhibition has been done for each PLconjugates tested on each bacterial strain. Thus, the solutions were considered as bactericidal when after incubation in the optimal conditions no colonies appears to grown in period of 24 hours or more.
First of all, we have found that: 1) the most active compounds were: C4-PL, C8-PL, C10-PL, C12-PL; 2) the major part of bacteria strains were sensitive. To increase the bactericidal effect of fatty acid-PL conjugate, we have combined different mixtures and found that the best was: C10-PL-C12 and C4-PL. This mixture was also tested on antibiotic multi-resistant gram -strains. The strongly bactericidal activity was obtained after: 1) 3 hours for Escherichia coli; 2) 5 hours for Pseudomonas aeruginosa.
These new drug candidates were effective on GRAM -bacteria inhibiting completely their development. The effects were independent of the cell wall. Our data show: 1) the importance of the fatty acid when they are linked to PL; 2) the efficacy of different products (bactericidal activities) on strains which were in some cases multi-resistant. These conjugates open new therapeutic perspectives for chronic diseases in which bacteria are implicated.
